IDEX (NYSE:IEX) Releases Quarterly Earnings Results, Beats Estimates By $0.22 EPS

IDEX (NYSE:IEX) announced its quarterly earnings results on Wednesday. The industrial products company reported $2.00 earnings per share for the quarter, beating the consensus estimate of $1.78 by $0.22, FiscalAI reports. IDEX had a return on equity of 15.29% and a net margin of 14.38%.The firm had revenue of $886.90 million during the quarter, compared to analyst estimates of $845.58 million. During the same quarter in the previous year, the business earned $1.75 EPS. IDEX’s revenue for the quarter was up 8.9% compared to the same quarter last year. IDEX updated its Q2 2026 guidance to 2.070-2.120 EPS and its FY 2026 guidance to 8.350-8.550 EPS.

Here are the key takeaways from IDEX’s conference call:

• Q1 beat and guidance raised: IDEX reported organic sales up 5%, Adjusted EBITDA margin of 26% (+50 bps YoY) and orders +10% organically, and raised full‑year organic growth to 3%–4% with Adjusted EPS now $8.35–$8.55.
• HST outperformance and backlog build: Health & Science Technologies drove momentum with orders +17% and organic revenue +11%, 100 bps margin expansion and a stronger backlog that management says increases visibility into growth into 2027 across data center, semiconductor and space & defense markets.
• Mixed performance in short‑cycle segments — FMT and FSDP lagging: FMT orders were +9% but sales only +2% (margin down 10 bps) and FSDP orders fell 4% with sales down 1%; management is forecasting flattish growth for these segments, which limits near‑term consolidated upside.
• Capital allocation and liquidity intact: IDEX repurchased $76M of stock in Q1 (plans to maintain quarterly pace), generated $86M FCF in the seasonally weak quarter, finished with ~2x gross leverage and an active bolt‑on M&A pipeline while keeping buybacks and dividends.

IDEX Price Performance

NYSE:IEX traded down $2.53 during trading hours on Friday, hitting $215.32. 629,704 shares of the stock were exchanged, compared to its average volume of 828,345. IDEX has a 52-week low of $157.25 and a 52-week high of $223.85. The firm’s fifty day moving average price is $198.99 and its 200 day moving average price is $187.76. The company has a current ratio of 3.39, a quick ratio of 2.02 and a debt-to-equity ratio of 0.46. The company has a market cap of $16.01 billion, a P/E ratio of 31.85, a P/E/G ratio of 2.16 and a beta of 0.99.

Wall Street Analyst Weigh In

Several brokerages recently weighed in on IEX. Royal Bank Of Canada lifted their price target on IDEX from $225.00 to $252.00 and gave the company an “outperform” rating in a research note on Thursday. TD Cowen lifted their price target on IDEX from $250.00 to $260.00 and gave the company a “buy” rating in a research note on Thursday. Weiss Ratings restated a “hold (c)” rating on shares of IDEX in a research note on Monday, April 20th. Robert W. Baird set a $257.00 price target on IDEX in a research note on Thursday. Finally, Oppenheimer restated an “outperform” rating and issued a $242.00 price target on shares of IDEX in a research note on Thursday. Six research analysts have rated the stock with a Buy rating and three have issued a Hold rating to the company’s stock. Based on data from MarketBeat, IDEX has an average rating of “Moderate Buy” and a consensus target price of $234.70.

Institutional Investors Weigh In On IDEX

Several large investors have recently bought and sold shares of IEX. Primecap Management Co. CA increased its stake in IDEX by 86.5% during the 4th quarter. Primecap Management Co. CA now owns 3,226,787 shares of the industrial products company’s stock worth $574,174,000 after buying an additional 1,496,207 shares in the last quarter. Dodge & Cox increased its stake in IDEX by 266.7% during the 4th quarter. Dodge & Cox now owns 1,262,550 shares of the industrial products company’s stock worth $224,658,000 after buying an additional 918,208 shares in the last quarter. Schonfeld Strategic Advisors LLC increased its stake in IDEX by 2,797.7% during the 4th quarter. Schonfeld Strategic Advisors LLC now owns 295,711 shares of the industrial products company’s stock worth $52,619,000 after buying an additional 285,506 shares in the last quarter. Arrowstreet Capital Limited Partnership increased its stake in IDEX by 138.8% during the 4th quarter. Arrowstreet Capital Limited Partnership now owns 463,262 shares of the industrial products company’s stock worth $82,433,000 after buying an additional 269,281 shares in the last quarter. Finally, Two Sigma Investments LP increased its stake in IDEX by 446.8% during the 3rd quarter. Two Sigma Investments LP now owns 329,337 shares of the industrial products company’s stock worth $53,603,000 after buying an additional 269,109 shares in the last quarter. 97.96% of the stock is currently owned by hedge funds and other institutional investors.

IDEX Company Profile

IDEX Corporation is a diversified industrial manufacturer specializing in the design, production and distribution of highly engineered fluidics systems, measurement technologies and safety solutions. The company’s core offerings include positive-displacement pumps, flow meters, valves, sampling systems and analytical instruments that serve a wide range of end markets such as water treatment, chemical processing, energy, food and beverage, and life sciences. Through its focus on precision engineering and proprietary material science, IDEX delivers products designed for reliability in demanding applications.

Operations at IDEX are organized into three principal segments.